Comprehensive, Evidence-Based Update on Disease-Modifying Therapies (DMTs) and Symptom Management in Multiple Sclerosis: A Clinical Overview for Physicians
I. Disease-Modifying Therapy (DMT) Indications & Goals Multiple sclerosis (MS) remains an immune-mediated demyelinating disease of the central nervous system (CNS), characterized by neuroinflammation, axonal transection, and progressive neurodegeneration. While no cure exists, early initiation of DMTs significantly alters long-term disease trajectory. Indications for DMT Initiation Treatment Goal Hierarchy (per AAN/ECTRIMS 2023 consensus): II. DMT…